California State Teachers Retirement System (CalSTRS)
ACAD icon

California State Teachers Retirement System (CalSTRS)’s Acadia Pharmaceuticals ACAD Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.08M Buy
138,244
+11,437
+9% +$273K ﹤0.01% 1299
2025
Q4 		$3.39M Buy
126,807
+26,110
+26% +$624K ﹤0.01% 1137
2025
Q3 		$2.15M Buy
100,697
+6
+0% +$142 ﹤0.01% 1366
2025
Q2 		$2.17M Buy
100,691
+1,412
+1% +$26.2K ﹤0.01% 1319
2025
Q1 		$1.65M Sell
99,279
-2,379
-2% -$43.2K ﹤0.01% 1437
2024
Q4 		$1.87M Sell
101,658
-576
-0.6% -$9.3K ﹤0.01% 1442
2024
Q3 		$1.57M Sell
102,234
-3,342
-3% -$55.8K ﹤0.01% 1530
2024
Q2 		$1.72M Sell
105,576
-3,246
-3% -$52.4K ﹤0.01% 1469
2024
Q1 		$2.01M Sell
108,822
-5,917
-5% -$147K ﹤0.01% 1407
2023
Q4 		$3.59M Sell
114,739
-5,478
-5% -$131K 0.01% 1087
2023
Q3 		$2.51M Sell
120,217
-20,020
-14% -$544K ﹤0.01% 1264
2023
Q2 		$3.36M Sell
140,237
-11,186
-7% -$249K ﹤0.01% 1183
2023
Q1 		$2.85M Sell
151,423
-2,198
-1% -$41.9K ﹤0.01% 1285
2022
Q4 		$2.45M Buy
153,621
+1,968
+1% +$30.8K ﹤0.01% 1352
2022
Q3 		$2.48M Sell
151,653
-2,649
-2% -$42.9K ﹤0.01% 1310
2022
Q2 		$2.17M Buy
154,302
+520
+0.3% +$9.71K ﹤0.01% 1440
2022
Q1 		$3.73M Sell
153,782
-13,036
-8% -$315K ﹤0.01% 1221
2021
Q4 		$3.89M Buy
166,818
+3,539
+2% +$71.2K ﹤0.01% 1315
2021
Q3 		$2.71M Sell
163,279
-16,689
-9% -$322K ﹤0.01% 1540
2021
Q2 		$4.39M Sell
179,968
-33,201
-16% -$749K 0.01% 1258
2021
Q1 		$5.5M Sell
213,169
-1,149
-0.5% -$50.6K 0.01% 1103
2020
Q4 		$11.5M Buy
214,318
+4,402
+2% +$219K 0.02% 709
2020
Q3 		$8.66M Buy
209,916
+21,631
+11% +$934K 0.01% 739
2020
Q2 		$9.13M Buy
188,285
+17,201
+10% +$826K 0.02% 697
2020
Q1 		$7.23M Sell
171,084
-847
-0.5% -$34.9K 0.02% 675
2019
Q4 		$7.36M Buy
171,931
+7,755
+5% +$337K 0.01% 811
2019
Q3 		$5.91M Buy
164,176
+1,961
+1% +$59.5K 0.01% 897
2019
Q2 		$4.34M Sell
162,215
-11,179
-6% -$286K 0.01% 1089
2019
Q1 		$4.66M Buy
173,394
+19,346
+13% +$452K 0.01% 1003
2018
Q4 		$2.49M Buy
154,048
+3,474
+2% +$67.5K 0.01% 1324
2018
Q3 		$3.13M Sell
150,574
-54
-0% -$850 0.01% 1330
2018
Q2 		$2.3M Buy
150,628
+46
+0% +$820 ﹤0.01% 1518
2018
Q1 		$3.38M Sell
150,582
-5,279
-3% -$146K 0.01% 1197
2017
Q4 		$4.69M Buy
155,861
+357
+0.2% +$11.4K 0.01% 1058
2017
Q3 		$5.86M Sell
155,504
-16,633
-10% -$541K 0.01% 895
2017
Q2 		$4.8M Sell
172,137
-17,923
-9% -$534K 0.01% 1057
2017
Q1 		$6.53M Sell
190,060
-8,600
-4% -$304K 0.01% 912
2016
Q4 		$5.73M Sell
198,660
-5,400
-3% -$143K 0.01% 989
2016
Q3 		$6.49M Buy
204,060
+12,800
+7% +$434K 0.01% 895
2016
Q2 		$6.21M Buy
191,260
+12,256
+7% +$410K 0.01% 895
2016
Q1 		$5M Buy
179,004
+31,317
+21% +$683K 0.01% 1016
2015
Q4 		$5.26M Buy
147,687
+2,323
+2% +$81.8K 0.01% 926
2015
Q3 		$4.81M Sell
145,364
-200
-0.1% -$8.32K 0.01% 969
2015
Q2 		$6.1M Buy
145,564
+1,138
+0.8% +$44K 0.01% 906
2015
Q1 		$4.71M Sell
144,426
-2,100
-1% -$72.2K 0.01% 1050
2014
Q4 		$4.65M Buy
146,526
+1,022
+0.7% +$29K 0.01% 1057
2014
Q3 		$3.6M Buy
145,504
+1,626
+1% +$38K 0.01% 1159
2014
Q2 		$3.25M Buy
143,878
+3,400
+2% +$71K 0.01% 1267
2014
Q1 		$3.42M Buy
140,478
+13,600
+11% +$344K 0.01% 1175
2013
Q4 		$3.17M Buy
126,878
+900
+0.7% +$21.2K 0.01% 1213
2013
Q3 		$3.46M Buy
125,978
+3,865
+3% +$80.8K 0.01% 1109
2013
Q2 		$2.22M Buy
+122,113
New +$1.68M 0.01% 1315

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ACAD Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Acadia Pharmaceuticals (ACAD) stake by 9% in Q1 2026, buying an estimated $273K and bringing the position to 138,244 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

California State Teachers Retirement System (CalSTRS) first reported a position in ACAD in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.5M in Q4 2020. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 138,244 shares of Acadia Pharmaceuticals worth $3.08M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 11,437 Acadia Pharmaceuticals shares in Q1 2026, an estimated $273K.
  • Acadia Pharmaceuticals made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1299 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Acadia Pharmaceuticals position peaked at $11.5M in Q4 2020.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.